137 related articles for article (PubMed ID: 9372858)
21. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
[TBL] [Abstract][Full Text] [Related]
22. Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer.
Ohno K; Utsumi T; Sasaki Y; Suzuki Y
Eur J Cardiothorac Surg; 2004 Apr; 25(4):492-6. PubMed ID: 15037260
[TBL] [Abstract][Full Text] [Related]
23. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
Cerón J; Peñalver JC; Jordá C; Padilla J
Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
25. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
[TBL] [Abstract][Full Text] [Related]
26. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
29. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
[TBL] [Abstract][Full Text] [Related]
30. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
[TBL] [Abstract][Full Text] [Related]
31. [Feasibility of limited surgery for small peripheral lung cancer].
Yamanda T; Hanaoka T; Machida M; Yoshida K; Miyazawa M; Aoki T; Hanyuda M; Amano J
Kyobu Geka; 1998 Jan; 51(1):17-21. PubMed ID: 9455064
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer.
Nakagawa T; Okumura N; Miyoshi K; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2005 Oct; 28(4):635-9. PubMed ID: 16126398
[TBL] [Abstract][Full Text] [Related]
33. [In what case can we abbreviate mediastinal lymph nodes dissection of peripheral small-sized lung cancer?].
Yamane Y; Shimada K; Ishida I
Kyobu Geka; 2004 Jan; 57(1):61-6. PubMed ID: 14733101
[TBL] [Abstract][Full Text] [Related]
34. Comparative characterization of pulmonary surfactant aggregates and alkaline phosphatase isozymes in human lung carcinoma tissue.
Iino N; Matsunaga T; Harada T; Igarashi S; Koyama I; Komoda T
Cell Tissue Res; 2007 May; 328(2):355-63. PubMed ID: 17216198
[TBL] [Abstract][Full Text] [Related]
35. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
36. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
37. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
Iwakiri S; Nagai S; Katakura H; Takenaka K; Date H; Wada H; Tanaka F
Ann Surg Oncol; 2009 Jun; 16(6):1678-85. PubMed ID: 19330380
[TBL] [Abstract][Full Text] [Related]
38. Expressions of Lewis antigens in human non-small cell pulmonary cancer and primary liver cancer with different pathological conditions.
Wang QY; Wu SL; Chen JH; Liu F; Chen HL
J Exp Clin Cancer Res; 2003 Sep; 22(3):431-40. PubMed ID: 14582703
[TBL] [Abstract][Full Text] [Related]
39. Transaortic EUS-guided FNA in the diagnosis of lung tumors and lymph nodes.
von Bartheld MB; Rabe KF; Annema JT
Gastrointest Endosc; 2009 Feb; 69(2):345-9. PubMed ID: 19100979
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
